Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol Hydrochloride
2. Fingolimod
3. Fty 720
4. Fty-720
5. Fty720
6. Gilenia
7. Gilenya
1. 162359-56-0
2. Fty720
3. Fingolimod Hcl
4. Gilenia
5. Gilenya
6. Fty 720
7. Fty-720
8. Fingolimod (hydrochloride)
9. Fingolimod (fty720) Hcl
10. 2-amino-2-(4-octylphenethyl)propane-1,3-diol Hydrochloride
11. Fingolimod, Hcl
12. Fty720 Hydrochloride
13. Fingolimod Hydrochloride [usan]
14. 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol Hydrochloride
15. Fty720 Free Base
16. Chebi:63112
17. Fingolimod Hydrochlorid
18. 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;hydrochloride
19. Fingolimod (as Hydrochloride)
20. Fty-720 Hydrochloride
21. 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol Hydrochloride
22. G926ec510t
23. Mfcd00939512
24. 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol Hydrochloride
25. Gilenya (tn)
26. 1,3-propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-, Hydrochloride
27. 1,3-propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-, Hydrochloride
28. 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, Hydrochloride
29. Fty-720a
30. Fingolimod (fty720)
31. Imusera
32. Unii-g926ec510t
33. 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol Hydrochloride
34. Fty720,fingolimod
35. Fingolimodhydrochloride
36. Fin;limod Hydrochloride
37. Fty720 - Fingolimod
38. Fingolimod Hclfty-720
39. Epitope Id:156573
40. Schembl81362
41. Mls006010179
42. Chembl544665
43. Fingolimod Hydrochloride- Bio-x
44. Dtxsid00167364
45. Ex-a960
46. Tdi-132
47. Bcpp000225
48. Bcp01808
49. 2-amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol Hcl
50. Fingolimod Hydrochloride (jan/usan)
51. Fingolimod Hydrochloride [mi]
52. S5002
53. Fingolimod Hydrochloride [jan]
54. Akos005145784
55. Ac-1929
56. Am84549
57. Bcp9000705
58. Ccg-265016
59. Cs-0114
60. Ks-1172
61. Fingolimod Hydrochloride [usp-rs]
62. Fingolimod Hydrochloride [who-dd]
63. Bf164458
64. Hy-12005
65. Smr004701287
66. Sy057854
67. Db-014816
68. A8548
69. F1018
70. Ft-0643569
71. Sw219384-1
72. Ec-000.2314
73. Fingolimod Hydrochloride [orange Book]
74. A25158
75. D04187
76. Fingolimod Hydrochloride [ep Monograph]
77. Fingolimod Hydrochloride [usp Monograph]
78. 359f560
79. Sr-01000942237
80. Q-101363
81. Sr-01000942237-2
82. Q27132395
83. 2-(4-octylphenethyl)-2-aminopropane-1,3-diol Hydrochloride
84. 2-amino-2-[2-(4-octylphenyl) Ethyl]-1,3-propanediol Hydrochloride
85. 2-amino-2-[2-(4-octylphenyl)-ethyl]-1,3-propanediol Hydrochloride
86. [1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl]azanium;chloride
87. 2-amino-2-[2-(4-n-octylphenyl)ethyl]propane-1,3-diol Hydrochloride
88. 2-amino-2-[2-(4-octyl-phenyl)-ethyl]-propane -1,3-diol Hydrochloride
89. 2-amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol Hydrochloride
90. 1,3-propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-, Hydrochloride (1:1)
Molecular Weight | 343.9 g/mol |
---|---|
Molecular Formula | C19H34ClNO2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 12 |
Exact Mass | 343.2278070 g/mol |
Monoisotopic Mass | 343.2278070 g/mol |
Topological Polar Surface Area | 66.5 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 258 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Gilenya |
PubMed Health | Fingolimod (By mouth) |
Drug Classes | Immune Modulator |
Drug Label | Fingolimod is a sphingosine 1-phosphate receptor modulator.Chemically, fingolimod is 2-amino-2-[2-(4-octylphenyl)ethyl]propan-1,3-diol hydrochloride. Its structure is shown below: Fingolimod hydrochloride is a white to practically white powder that i... |
Active Ingredient | Fingolimod |
Dosage Form | Capsule |
Route | Oral |
Strength | 0.5mg |
Market Status | Prescription |
Company | Novartis |
2 of 2 | |
---|---|
Drug Name | Gilenya |
PubMed Health | Fingolimod (By mouth) |
Drug Classes | Immune Modulator |
Drug Label | Fingolimod is a sphingosine 1-phosphate receptor modulator.Chemically, fingolimod is 2-amino-2-[2-(4-octylphenyl)ethyl]propan-1,3-diol hydrochloride. Its structure is shown below: Fingolimod hydrochloride is a white to practically white powder that i... |
Active Ingredient | Fingolimod |
Dosage Form | Capsule |
Route | Oral |
Strength | 0.5mg |
Market Status | Prescription |
Company | Novartis |
Gilenya is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older:
- Patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 and 5. 1).
or
- Patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.
Sphingosine 1 Phosphate Receptor Modulators
Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)
Immunosuppressive Agents
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)
L04AA27
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-20
Pay. Date : 2014-04-25
DMF Number : 28148
Submission : 2014-04-27
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-20
Pay. Date : 2014-06-16
DMF Number : 28225
Submission : 2014-04-22
Status : Active
Type : II
Certificate Number : R0-CEP 2019-171 - Rev 01
Issue Date : 2023-07-27
Type : Chemical
Substance Number : 2988
Status : Valid
Date of Issue : 2019-07-26
Valid Till : 2022-05-05
Written Confirmation Number : WC-0362
Address of the Firm :
NDC Package Code : 69037-0006
Start Marketing Date : 2010-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-17
Pay. Date : 2014-04-15
DMF Number : 28165
Submission : 2014-04-23
Status : Active
Type : II
Certificate Number : CEP 2019-140 - Rev 01
Issue Date : 2024-10-25
Type : Chemical
Substance Number : 2988
Status : Valid
Registration Number : 304MF10011
Registrant's Address : Xiaba Development Zone, Ruyuan County, Shaoguan City, Guangdong Province, P. R. China
Initial Date of Registration : 2022-01-13
Latest Date of Registration : --
141.1k
51 - 200
19.2
2.7M
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|---|---|---|
JORDAN | 1.78 | 1,64,844.2 | <10 |
TURKEY | 2.61 | 72,442.3 | <10 |
BRAZIL | 2.02 | 2,36,598.4 | <10 |
EGYPT | 2.78 | 1,29,441.4 | <10 |
SAUDI ARABIA | 1.61 | 1,90,745.6 | <10 |
ARGENTINA | 0.29 | 1,52,043.8 | <10 |
FRANCE | 0.30 | 3,45,696.7 | <10 |
GERMANY | 0.74 | 1,20,113.0 | <10 |
CHINA | 0.40 | 2,91,308.0 | <10 |
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?